Health Product InfoWatch: February 2021 - InfoVigilance sur les produits de santé: février 2021
Health Product InfoWatch, published monthly by Health Canada, includes a recap of health product advisories and summary safety reviews published in the previous month, as well as a growing selection of new health product safety information. The goal of the Health Product InfoWatch is to…
Health Canada: Special Access Program Regulations Changes
Health Canada’s Special Access Program (SAP), and the Emergency Drug Release (EDR) Program are used when a serious or life-threatening condition may require new drugs when conventional therapies have failed, are unsuitable, or unavailable. The regulations surrounding these programs are currently be…
Health Canada: Cost-Benefit Analysis Survey for Transitioning Regulations of Interim Orders into Permanent Regulations
In 2020, Health Canada developed interim orders to help prevent and alleviate drug and medical device shortages. The interim orders & measures are with respect to: (1) Drugs, Medical Devices, and Foods for a Special Dietary Purpose in Relation to COVID-19 can be found here (2)…
Health Canada: Quarterly Updates on Mandatory Reporting
Health Canada has recently shared their quarterly update from the Canada Vigilance Program (CVP) to provide information regarding mandatory reporting by hospitals. Since the coming into force of the regulations for mandatory reporting on December 16, 2019, all hospitals across the country are …
Health Canada: Canadians invited to share their views on a National Strategy for High-Cost Drugs for Rare Diseases
Rare diseases can start in early childhood or at birth, and there are between 6,000 and 8,000 different rare diseases identified to date. Health Canada is looking for Canadians to share their views on what a national strategy may look like to assist Canadians who require high-cost drugs for rare-di…
Health Product InfoWatch: January - InfoVigilance sur les produits de santé: janvier
Health Product InfoWatch, published monthly by Health Canada, includes a recap of health product advisories and summary safety reviews published in the previous month, as well as a growing selection of new health product safety information. The goal of the Health Product InfoW…
Feedback Request for Health Canada Exceptional Importation Interim Order
An interim order by the Minister of Health was developed on March 30, 2020, that permitted exceptional importation and sale of drugs, medical devices, and foods for a special dietary purpose to address shortages of those products caused or exacerbated by COVID-19. Health Canada is now proposing to …
CSHP's response to Health Canada Consultation on amending the Food and Drug Regulations to expedite access to COVID-19 drugs
Click here for more information on the Interim Order created to respond to the need for urgent COVID-19 treatment or prevention options
CSHP's response to Health Canada Consultation on Pathogens of Interest List
Click here for more information on the call for feedback on the Pathogens of Interest list.
An Aging Population and Increased prevalence of Chronic Diseases in Canada
Dr. Theresa Tam, the Chief Public Health Officer, comments on the risks seniors face in today’s pandemic in the new Aging and Chronic Diseases: A Profile of Canadian Seniors report. This report highlights seniors being at inherently higher risk of worse outcomes with a COVID -19 infection due t…
Categories
- A.P.E.S.
- Advocacy
- Choosing Wisely Canada
- CJHP
- Health Canada
- PPC 2020
- CSHP News
- Corporate
- CPRB | RB News
- CSHP Foundation
- Distinguished Service Award Corner
- Membership
- Products and Publications
- PSNs
- Year in Review Reports
- Webinar
- ISMP Canada Safety Bulletin
- Volunteer Opportunities
- Surveys and Consultations
- Non-CSHP News
Pharmacy Job Opportunities
Professional Practice Specialist (Full-Time Position)
Professional Practice Specialist
Date Posted: February 18, 2021
Location: Ottawa, Ontario
All Job Opportunities